Immediate Impact
2 from Science/Nature 53 standout
Citing Papers
Heat shock proteins: Biological functions, pathological roles, and therapeutic opportunities
2022 Standout
Cervical cancer therapies: Current challenges and future perspectives
2022 Standout
Works of Mark Yancey being referenced
A phase I combination study of olaparib (AZD2281; KU-0059436) and cisplatin (C) plus gemcitabine (G) in adults with solid tumors.
2010
Phase I trial of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) administered twice weekly
2007
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Mark Yancey | 95 | 108 | 34 | 57 | 12 | 293 | |
| Akhil Bhargava | 88 | 41 | 17 | 20 | 20 | 274 | |
| Jerome H. Gass | 56 | 24 | 13 | 23 | 13 | 309 | |
| Andrew J. Spencer | 79 | 36 | 30 | 38 | 10 | 312 | |
| Shen-Jue Chen | 90 | 37 | 26 | 35 | 13 | 245 | |
| Isabelle Solassol | 101 | 49 | 11 | 83 | 17 | 320 | |
| Melvin Greenblatt | 91 | 48 | 11 | 17 | 16 | 325 | |
| Emma Hurst | 58 | 36 | 19 | 49 | 15 | 330 | |
| Fujiho Tanaka | 78 | 37 | 44 | 38 | 21 | 273 | |
| C Biancifiori | 108 | 22 | 15 | 31 | 22 | 289 | |
| Kosei Inui | 67 | 57 | 24 | 32 | 14 | 247 |
All Works
Loading papers...